Parametric Portfolio Associates’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$9.25M Sell
251,287
-17,299
-6% -$637K ﹤0.01% 1410
2021
Q4
$12.2M Buy
268,586
+11,896
+5% +$542K 0.01% 1255
2021
Q3
$9.17M Buy
256,690
+84,307
+49% +$3.01M 0.01% 1419
2021
Q2
$3.41M Buy
172,383
+5,778
+3% +$114K ﹤0.01% 2117
2021
Q1
$3.88M Buy
166,605
+10,396
+7% +$242K ﹤0.01% 2339
2020
Q4
$3.25M Buy
156,209
+1,893
+1% +$39.3K ﹤0.01% 2361
2020
Q3
$3.34M Sell
154,316
-33,645
-18% -$728K ﹤0.01% 2165
2020
Q2
$4.43M Buy
187,961
+65,348
+53% +$1.54M ﹤0.01% 1956
2020
Q1
$1.45M Buy
122,613
+21,680
+21% +$256K ﹤0.01% 2578
2019
Q4
$1.07M Sell
100,933
-15,420
-13% -$164K ﹤0.01% 3030
2019
Q3
$1.32M Buy
116,353
+11,783
+11% +$134K ﹤0.01% 2878
2019
Q2
$1.18M Buy
104,570
+25,783
+33% +$290K ﹤0.01% 2969
2019
Q1
$637K Sell
78,787
-3,267
-4% -$26.4K ﹤0.01% 3228
2018
Q4
$519K Buy
82,054
+21,024
+34% +$133K ﹤0.01% 3295
2018
Q3
$601K Buy
61,030
+26,651
+78% +$262K ﹤0.01% 3344
2018
Q2
$285K Sell
34,379
-11,089
-24% -$91.9K ﹤0.01% 3570
2018
Q1
$327K Buy
45,468
+20,263
+80% +$146K ﹤0.01% 3540
2017
Q4
$205K Sell
25,205
-11,882
-32% -$96.6K ﹤0.01% 3745
2017
Q3
$538K Buy
37,087
+14,072
+61% +$204K ﹤0.01% 3380
2017
Q2
$278K Buy
23,015
+9,682
+73% +$117K ﹤0.01% 3665
2017
Q1
$171K Buy
13,333
+189
+1% +$2.42K ﹤0.01% 3624
2016
Q4
$160K Sell
13,144
-56
-0.4% -$682 ﹤0.01% 3637
2016
Q3
$121K Sell
13,200
-996
-7% -$9.13K ﹤0.01% 3650
2016
Q2
$135K Sell
14,196
-54,925
-79% -$522K ﹤0.01% 3686
2016
Q1
$487K Buy
69,121
+43,405
+169% +$306K ﹤0.01% 3345
2015
Q4
$269K Buy
25,716
+7,594
+42% +$79.4K ﹤0.01% 3602
2015
Q3
$121K Buy
18,122
+804
+5% +$5.37K ﹤0.01% 3168
2015
Q2
$116K Sell
17,318
-34
-0.2% -$228 ﹤0.01% 3858
2015
Q1
$118K Buy
17,352
+2,622
+18% +$17.8K ﹤0.01% 3839
2014
Q4
$118K Buy
+14,730
New +$118K ﹤0.01% 3887